Cocaine and methamphetamine use disorder: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 0
• NRF2 0

24 of 143 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Implementing a Contingency Management Program Addressing Methamphetamine Use for and With the People of Hawai'i

  NCT06931197· Queen's Medical Center· Updated 18 Sept 2026

  “The study never commenced. The funding went through as year 2 for NCT06532370”Registry text, quoted unchanged. Source

• Terminated

  Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

  NCT05322954· University of Wisconsin, Madison· Updated 12 May 2026

  “due to sponsor financial constraints”Registry text, quoted unchanged. Source

• Suspended

  Safety Profile of Psilocybin for Cocaine Use Disorder

  NCT06102434· University of California, Los Angeles· Updated 7 Apr 2026

  “Departmental support”Registry text, quoted unchanged. Source

• Withdrawn

  Exenatide For Reducing the Reinforcing Effects of Cocaine

  NCT06252623· Christopher D. Verrico· Updated 13 Mar 2026

  “The study was closed due to the inability to acquire the study drug.”Registry text, quoted unchanged. Source

• Terminated

  Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation

  NCT04228276· VA Office of Research and Development· Updated 29 Aug 2025

  “COVID-19 pandemic adversely affected recruitment.”Registry text, quoted unchanged. Source

• Terminated

  Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)

  NCT06045793· Tonix Pharmaceuticals, Inc.· Updated 24 Jun 2025

  “Tonix has discontinued enrollment and terminated the Phase 2 CATALYST study (TNX-CE-CI202) because enrollment in this emergency department-based study was slower than projected. The study was not discontinued for safety or efficacy reasons.”Registry text, quoted unchanged. Source

• Terminated

  The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder

  NCT05711862· The University of Texas Health Science Center, Houston· Updated 29 Apr 2025

  “Lack of enrollment”Registry text, quoted unchanged. Source

• Terminated

  The Longitudinal Study of Stimulant Use Disorder

  NCT06073340· University of Texas Southwestern Medical Center· Updated 8 Apr 2025

  “Funding”Registry text, quoted unchanged. Source

• Terminated

  Monthly Injectable BUP for MA Use Disorder (MURB) Trial

  NCT05283304· Madhukar H. Trivedi, MD· Updated 21 Mar 2025

  “Side effects of medication”Registry text, quoted unchanged. Source

• Terminated

  Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction

  NCT03423667· Salvatore Campanella· Updated 7 Feb 2025

  “Difficulties in recruitment (single addictions become rare)”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy

  NCT07849530· University of Utah· Source

• Rehabilitation Program for People With Methamphetamine-Associated Cardiopulmonary Conditions

  NCT07915882· Michael Incze· Source

• rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

  NCT05974202· New York State Psychiatric Institute· Source

• Remote Intervention to Prevent Overdose

  NCT07128485· University of Alabama at Birmingham· Source

• Efficacy of Adaptive, Gamified Digital Therapeutics Intervention for Individuals With Methamphetamine Use Disorder in Community Rehabilitation

  NCT07319325· Adai Technology (Beijing) Co., Ltd.· Source

• PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)

  NCT07886944· Chestnut Health Systems· Source

• Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder

  NCT07825857· University of Texas Southwestern Medical Center· Source

• Transcranial Direct Current Stimulation (tDCS) for Treatment of Substance Use Disorder

  NCT07318480· Icahn School of Medicine at Mount Sinai· Source

• Examination of Transcranial Focused Ultrasound on Brain Activity in Adults With Cocaine Use Disorder

  NCT07852923· Mary Phillips, MD MD (Cantab)· Source

• Psilocybin for Methamphetamine Use Disorder

  NCT07774702· Peter Hendricks· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 2
• Gene Expression Profiling 1
• Exome Sequencing 1
• Proteomics 2
• Metabolomics 3
• Mass Spectrometry 1
• Immunohistochemistry 1
• Positron-Emission Tomography 2
• Magnetic Resonance Imaging 25
• Machine Learning 1
• Deep Learning 1
• Cohort Studies 3
• Genome-Wide Association Study 1

See which targets of this disease your abstract mentions, and go to the people working on them.